Exogenous supplementation of N-acetylcysteine can reduce hepatotoxicity induced by ascites fluid (cell-free) adsorbed over Protein-A-containing Staphylococcus aureus Cowan-I without compromising its antitumor effect†

Ashish S Verma; Priyadarshini Mallick; Premendra D Dwivedi; Anchal Singh

doi:10.4103/jpbs.JPBS_216_18

Journal of Pharmacy And Bioallied Sciences

	Login \| Users Online: 649
	Home \| About us \| Editorial board \| Search \| Ahead of print \| Current Issue \| Past Issues \| Instructions \| Online submission

ORIGINAL ARTICLE

Year : 2019 | Volume : 11 | Issue : 3 | Page : 205-215

Exogenous supplementation of N-acetylcysteine can reduce hepatotoxicity induced by ascites fluid (cell-free) adsorbed over Protein-A-containing Staphylococcus aureus Cowan-I without compromising its antitumor effect^†

Ashish S Verma¹, Priyadarshini Mallick², Premendra D Dwivedi³, Anchal Singh⁴
¹ Jadavpur University, Kolkata, West Bengal, India
² Department of Microbiology, Asutosh College, Bhowanipore, Kolkata, West Bengal, India
³ Food, Drug and Chemical Toxicology Group, Academy of Scientific and Innovative Research (AcSIR), Lucknow, Uttar Pradesh, India
⁴ Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, India

Correspondence Address:
Prof. Ashish S Verma
Aurobindo Bhavan, Jadavpur University, 188 Raja S. C. Mallick Road, Kolkata 700 032, West Bengal
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/jpbs.JPBS_216_18

Introduction: Hepatotoxicity along with enhanced mortality has remained a major concern during the development of antitumor therapy with the use of cell-free ascites fluid adsorbed (ad-AF) over Protein-A-containing Staphylococcus aureus Cowan I (SAC). Major issue with ad-AF inoculation is the significant depletion of hepatic glutathione (GSH). Exogenous supplementation of –SH contents to the host has offered an encouraging hope to explore the possibilities to use ad-AF as a therapeutic material due to its antitumor effects. GSH and l-cysteine have shown a promise with the recovery of –SH contents as well as the recovery of phase I and phase II biotransformation enzymes. Aforementioned observations prompted us to try other –SH donors. Materials and Methods: Therefore, in this study, N-acetylcysteine (NAC) was used as an exogenous source to provide –SH contents to reduce hepatotoxicity and mortality induced by ad-AF treatment. Results: Exogenous supplementation of NAC along with ad-AF treatment to ascites tumor bearers has shown a significant protection against hepatotoxicity and mortality caused by ad-AF. NAC substitution along with ad-AF has significantly enhanced the mean survival time (MST), without altering the antitumor effect of ad-AF as evident from tumor cell counts and viability. Discussion: NAC supplementation has been successful to recover hepatic –SH contents along with the significant recovery of phase I and phase II biotransformation enzymes. Marker enzymes for liver injury have also given clear-cut indications for the recovery of tumor bearers from hepatotoxicity induced by ad-AF. Conclusion: This study has shown that exogenous supplementation of NAC protects the host from the enhanced mortality and hepatotoxicity induced by ad-AF. These observations offer a hope to develop ad-AF as one of the probable treatment strategies for ascites tumors at least at experimental levels.

[FULL TEXT] [PDF]*

Table of Contents

suppl

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	1938

Printed	67

Emailed	0

PDF Downloaded	115

Comments	[Add]

Cited by others	1